We are live on ! Find out more
PA

Perceptive Advisors Portfolio holdings

AUM $6.66B
1-Year Est. Return 360.84%
This Fund
S&P 500
This Quarter Est. Return
+32.47%
1 Year Est. Return
+360.84%
3 Year Est. Return
+1,707.27%
5 Year Est. Return
+3,210.42%
10 Year Est. Return
+53,055.89%
AUM
$6.66B
AUM Growth
+$1.54B
Cap. Flow
+$235M
Cap. Flow %
3.53%
Top 10 Hldgs %
47.3%
Holding
121
New
27
Increased
30
Reduced
28
Closed
12

Top Buys

Rank Stock Value
1
KARD
Kardigan Inc
KARD
+$190M
2
AVLN
Avalyn Pharma
AVLN
+$77.2M
3
TNGX icon
Tango Therapeutics
TNGX
+$63.5M
4
RLAY icon
Relay Therapeutics
RLAY
+$63.2M
5
BIIB icon
Biogen
BIIB
+$52.8M

Top Sells

Rank Stock Value
1
CNTA
Centessa Pharmaceuticals
CNTA
+$209M
2
ASND icon
Ascendis Pharma A/S
ASND
+$85.9M
3
DAWN
Day One Biopharmaceuticals
DAWN
+$37.6M
4
DYN icon
Dyne Therapeutics
DYN
+$36.8M
5
ABVX
Abivax
ABVX
+$28.8M

Sector Composition

Rank Sector Weight
1 Healthcare 96.3%
2 Miscellaneous 3.58%
3 Financials 0.12%

No holdings matched the selected filter criteria.

1 2 3 4 5

Similar funds

QP
Quilter Plc London, United Kingdom $6.65B AUM 37.83% 1-Year Est. Return
FCBT
First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return
RWM
Ritholtz Wealth Management New York $6.7B AUM 32.7% 1-Year Est. Return
AWA
Arkadios Wealth Advisors Atlanta, Georgia $6.6B AUM 30.67% 1-Year Est. Return
WHRC
W.H. Reaves & Co Jersey City, New Jersey $6.59B AUM 31.9% 1-Year Est. Return
KGA
K5 Global Advisor Miami Beach, Florida $6.59B AUM
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $6.74B AUM 30.22% 1-Year Est. Return

Perceptive Advisors's Q2 2026 Portfolio in Review

As of Q2 2026, Perceptive Advisors held 121 positions worth $6.66B, up 30% from $5.12B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Perceptive Advisors deployed $235M of net new capital in Q2 2026, opening 27 new positions and adding to 30 existing holdings. Its largest new stake was Kardigan Inc: 8,200,662 shares worth $196M.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, down from 99% a quarter earlier, followed by Miscellaneous and Financials.

On the sell side, the largest reduction was Ascendis Pharma A/S, an estimated $85.9M trimmed.

  • Perceptive Advisors's largest Q2 2026 buy was Kardigan Inc: 8,200,662 shares worth $196M.
  • Perceptive Advisors added most to Tango Therapeutics in Q2 2026, an estimated $63.5M increase.
  • Perceptive Advisors's biggest Q2 2026 reduction was Ascendis Pharma A/S, cutting an estimated $85.9M.
  • Perceptive Advisors fully exited Centessa Pharmaceuticals in Q2 2026, selling an estimated $209M.
  • Perceptive Advisors's ten largest holdings make up 47% of its $6.66B portfolio in Q2 2026.
  • Perceptive Advisors opened 27 new positions and closed 12 in Q2 2026.
  • Perceptive Advisors's portfolio value rose 30% quarter-over-quarter to $6.66B.

Based on Perceptive Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.